Estados financieros detallados de HeartSciences Inc. (HSCS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
HeartSciences Inc. registró ingresos de $4319 en el último ejercicio fiscal, con un CAGR de 5 años del -29.9%.
Márgenes de los últimos 12 meses: margen bruto -29.8%, margen operativo -1947.9%, margen neto -2116.7%.
Al precio actual de $3.79, HSCS presenta beneficios negativos (P/E no significativo) y un ROE del -358.44%. La capitalización bursátil es de $8M.
Cuenta de Resultados (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|
| Ingresos | $64182 | $25604 | $14373 | $5150 | $18600 | $4350 | $4319 |
| Coste de Ventas | $110287 | $44276 | $34456 | $29711 | $101214 | $129836 | $133118 |
| Beneficio Bruto | -$46105 | -$18672 | -$20083 | -$24561 | -$82614 | -$125485 | -$128799 |
| I+D | $2.0M | $1.7M | $3.0M | $2.5M | $2.9M | $4.4M | $2.84B |
| Generales y Administrativos | $1.7M | $841009 | $1.7M | $3.6M | $3.3M | $3.8M | $5.58B |
| Gastos Operativos | $3.8M | $2.5M | $4.7M | $6.1M | $6.2M | $8.2M | $8.3M |
| Beneficio Operativo | -$3.8M | -$2.6M | -$4.7M | -$6.1M | -$6.3M | -$8.4M | -$8.4M |
| EBITDA | -$3.7M | -$2.3M | -$4.4M | -$6.1M | -$6.2M | -$8.2M | -$8.4M |
| Gastos por Intereses | $2811 | $132454 | $371619 | $243174 | $354080 | $500453 | $753041 |
| Beneficio Antes de Impuestos | -$3.8M | -$2.5M | -$4.8M | -$6.4M | -$6.6M | -$8.8M | -$9.1M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$3.8M | -$2.5M | -$4.8M | -$6.4M | -$6.6M | -$8.8M | -$9.1M |
| BPA | $-115.69 | $-77.89 | $-145.48 | $-79.92 | $-18.74 | $-9.34 | $-3.48 |
| BPA Diluido | $-115.69 | $-77.89 | $-145.48 | $-79.92 | $-18.74 | $-9.34 | $-3.48 |
| Acciones en Circulación (Diluidas) | $33138 | $33138 | $33189 | $79505 | $352520 | $938257 | $2.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q4 | 2025-Q4 | 2026-Q1 | 2026-Q3 |
|---|
| Ingresos | $2419 | 0 | 0 | $2100 |
| Beneficio Bruto | -$31024 | -$34000 | -$33238 | -$33188 |
| Beneficio Operativo | -$2.1M | -$2.5M | -$1.9M | -$2.9M |
| EBITDA | -$2.0M | -$2.6M | -$1.9M | -$2.9M |
| Beneficio Neto | -$2.4M | -$2.8M | -$2.0M | -$3.2M |
| BPA | $-0.85 | $-0.86 | $-0.63 | $-0.86 |
| BPA Diluido | $-0.85 | $-0.86 | $-0.63 | $-0.86 |
Balance (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caja y Equivalentes | $496853 | $723481 | $918260 | $1.7M | $5.8M | $1.1M | $1.66B |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $2321 | 0 | 0 | $4350 | 0 |
| Inventario | $857008 | $750774 | $674139 | $676359 | $629179 | $650267 | $655.6M |
| Activos Corrientes | $1.5M | $1.6M | $1.9M | $2.7M | $7.4M | $2.2M | $2.58B |
| Inmovilizado Material | $418047 | $289329 | $158570 | $590652 | $559974 | $435175 | $307.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $1.6M | $1.6M | $2.37B |
| Activos Totales | $2.0M | $1.9M | $2.1M | $3.3M | $9.5M | $4.2M | $5.26B |
| Cuentas por Pagar | $358786 | $335781 | $694745 | $631369 | $448183 | $318661 | $318.3M |
| Deuda a Corto | $350766 | $380200 | $1.6M | $500000 | $500000 | $2.6M | $3.62B |
| Pasivos Corrientes | $1.1M | $1.1M | $3.5M | $1.8M | $1.8M | $3.7M | $4.86B |
| Deuda a Largo | $300000 | $2.5M | $4.4M | $500000 | 0 | 0 | 0 |
| Pasivos Totales | $1.6M | $3.8M | $8.1M | $3.1M | $2.2M | $4.0M | $5.04B |
| Reservas | -$47.1M | -$49.6M | -$54.4M | -$60.8M | -$67.4M | -$76.1M | -$85.27B |
| Patrimonio Neto | $315551 | -$1.9M | -$6.1M | $230557 | $7.3M | $205171 | $225.5M |
| Deuda Total | $942710 | $3.1M | $6.2M | $1.6M | $1.0M | $3.0M | $3.94B |
| Deuda Neta | $445857 | $2.4M | $5.2M | -$94597 | -$4.8M | $1.9M | $2.28B |
| Capital Circulante | $396103 | $524282 | -$1.5M | $863690 | $5.6M | -$1.5M | -$2.28B |
Balance (Trimestral)
| Año | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q3 |
|---|
| Caja y Equivalentes | $2.0M | $3.40B | $1.66B | $29.9M |
| Activos Totales | $6.0M | $7.6M | $5.3M | $3.7M |
| Pasivos Totales | $1.8M | $4.9M | $5.0M | $5.8M |
| Patrimonio Neto | $4.2M | $2.7M | $226060 | -$2.0M |
| Deuda Total | $876240 | $3.9M | $3.9M | $4.0M |
Flujo de Caja (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|
| Beneficio Neto | -$3.8M | -$2.5M | -$4.8M | -$6.4M | -$6.6M | -$8.8M | -$9.1M |
| Amortizaciones | $63827 | $33611 | $26566 | $135453 | $95133 | $127956 | $131350 |
| Compensación en Acciones | $135067 | $24675 | $68396 | $248307 | $405025 | $249884 | $1.3M |
| Cambio en Capital Circulante | -$195965 | $190127 | $1.1M | $65446 | -$504363 | $517888 | -$1.1M |
| Flujo de Caja Operativo | -$3.8M | -$2.5M | -$3.6M | -$5.8M | -$6.1M | -$7.4M | -$7.4M |
| Inversiones (CapEx) | -$11424 | -$712 | -$1932 | -$18308 | -$125271 | -$30188 | -$44452 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.9M | -$2.5M | -$3.6M | -$5.8M | -$6.2M | -$7.4M | -$7.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q4 | 2025-Q4 | 2026-Q1 | 2026-Q3 |
|---|
| Flujo de Caja Operativo | -$2.3M | -$1.7M | -$1.5M | -$1.32B |
| Inversiones (CapEx) | -$15770 | 0 | -$27868 | 0 |
| Flujo de Caja Libre | -$2.4M | -$1.7M | -$1.5M | -$1.32B |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $436884 | $324841 | $376100 | $738.9M |
Crecimiento y Márgenes (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -60.1% | -43.9% | -64.2% | +261.2% | -76.6% | -0.7% |
| Crecimiento Beneficio Neto (anual) | | +35.7% | -96.9% | -31.6% | -3.9% | -32.7% | -4.3% |
| Crecimiento BPA (anual) | | +32.7% | -86.8% | +45.1% | +76.6% | +50.2% | +62.7% |
| Cambio en Acciones (anual) | | +0.0% | +0.2% | +139.6% | +343.4% | +166.2% | +179.8% |
| Crecimiento FCF (anual) | | +36.3% | -48.6% | -58.9% | -7.0% | -20.1% | -0.4% |
| Margen Bruto | -71.8% | -72.9% | -139.7% | -476.9% | -444.2% | -2884.7% | -2982.1% |
| Margen Operativo | -5949.0% | -10030.2% | -32765.6% | -118698.3% | -33902.0% | -192013.1% | -194787.4% |
| Margen EBITDA | -5834.2% | -8928.7% | -30822.2% | -118139.8% | -33096.7% | -189071.6% | -194787.4% |
| Margen Neto | -5938.0% | -9577.3% | -33592.6% | -123384.3% | -35511.9% | -201499.5% | -211666.5% |
| Margen FCF | -6000.8% | -9580.6% | -25367.5% | -112463.8% | -33308.9% | -171107.6% | -172983.5% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|
| FCF por Acción | $-116.22 | $-74.02 | $-109.86 | $-72.85 | $-17.57 | $-7.93 | $-2.85 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $33138 | $33138 | $33189 | $79505 | $352520 | $938257 | $2.6M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -358.44% |
| Rentabilidad sobre capital invertido | -202.10% |
| Rentabilidad sobre activos | -173.71% |
| Margen bruto | -2982.10% |
| Margen operativo | -194787.38% |
| Margen neto | -211666.47% |
Salud financiera
| Deuda / Patrimonio | 17.41 |
| Ratio corriente | 0.50 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -31.71 |
Ratios Clave (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/E | -1.47 | -2.18 | -1.17 | -1.06 | -0.49 | -0.38 | -0.56 |
| P/VC | 17.85 | -2.95 | -0.93 | 29.14 | 0.45 | 16.05 | 0.02 |
| P/V | 87.77 | 220.02 | 392.55 | 1304.65 | 175.12 | 757.08 | 1185.36 |
| Margen Bruto | -71.8% | -72.9% | -139.7% | -476.9% | -444.2% | -2884.7% | -2982.1% |
| Margen Operativo | -5949.0% | -10030.2% | -32765.6% | -118698.3% | -33902.0% | -192013.1% | -194787.4% |
| Margen Neto | -5938.0% | -9577.3% | -33592.6% | -123384.3% | -35511.9% | -201499.5% | -211666.5% |